TAZAROTENE

Generic: TAZAROTENE

Padagis Israel Pharmaceuticals LtdManufacturer
TOPICALRoute
TAZAROTENEActive Substance
2023-04-25Original Approval

TAZAROTENE is FDA application ANDA213079, sponsored by PADAGIS ISRAEL. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
DRUG INEFFECTIVE
49 reports
2
OFF LABEL USE
34 reports
3
HEADACHE
16 reports
4
NAUSEA
16 reports
5
DIARRHOEA
15 reports
6
PRODUCT USE IN UNAPPROVED INDICATION
14 reports
7
PSORIASIS
14 reports
8
APPLICATION SITE DISCOLOURATION
13 reports
9
PAIN
11 reports
10
PRURITUS
11 reports